Viewing Study NCT02211157


Ignite Creation Date: 2025-12-24 @ 6:40 PM
Ignite Modification Date: 2025-12-27 @ 6:56 PM
Study NCT ID: NCT02211157
Status: COMPLETED
Last Update Posted: 2014-08-08
First Post: 2014-08-05
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety, Pharmacokinetics and Pharmacodynamics of BIRB 796 BS Tablets Administered to Healthy Human Subjects
Sponsor: Boehringer Ingelheim
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module